[Research progress on liver fibrosis, cirrhosis, and portal hypertension in 2024]. [PDF]
Xin SL, Xu XY.
europepmc +1 more source
[A stable mouse model of chronic liver fibrosis induced by vitamin A deficiency and intraperitoneal CCl<sub>4</sub> injection]. [PDF]
Yang T, Zhao L.
europepmc +1 more source
[Role of serum Golgi protein 73 in the assessment of pathological prognosis and its inflammatory influencing factors for hepatitis B virus-related liver fibrosis]. [PDF]
Fan HN +5 more
europepmc +1 more source
[Protective effect of knock-down the expression of <i>Blimp1</i> gene on early liver injury in CCl<sub>4</sub>-induced mouse model of liver fibrosis]. [PDF]
Qin Q +5 more
europepmc +1 more source
[Study on the mechanism of Fuzheng Huayu formula against biliary fibrosis in mice]. [PDF]
Zhang Z +9 more
europepmc +1 more source
[Research progress on the mechanistic role and constituents of hepatic macrophages during the occurrence and development of hepatic fibrosis]. [PDF]
Liu RX, Liu JF, Xu P.
europepmc +1 more source
[Research progress on the diagnostic performance and predictive accuracy of different prognostic scores as non-invasive liver fibrosis models for primary biliary cholangitis]. [PDF]
Feng J +5 more
europepmc +1 more source
[Meta-analysis of the efficacy of the Fuzheng Huayu formula in the treatment of hepatitis B-associated liver fibrosis or cirrhosis]. [PDF]
Fan Y +5 more
europepmc +1 more source
[Role of metabolic reprogramming-mediated hepatic stellate cell activation in the pathogenesis of hepatic fibrosis]. [PDF]
Xiao Y, Wu ZN, Lu J, Wang YD.
europepmc +1 more source
[Compound <i>Centella asiatica</i> formula alleviates <i>Schistosoma japonicum</i>-induced liver fibrosis in mice by inhibiting the inflammation-fibrosis cascade via regulating the TLR4/MyD88 pathway]. [PDF]
Guan L +11 more
europepmc +1 more source

